UPELVA gouttes buvables fl 50 ml

7680553260217 Pharmacode 1965863 CH-55326 20.01.2.
UPELVA gouttes buvables fl 50 ml
Fiches Amavita / Sun Store / Coop Vitality

Details

GTIN
7680553260217
Pharmacode
1965863
Product number
5532601
CPT
-
Packaging group
50
Unit
ml
Composition
chamaelirium luteum (HAB) D6 125 mg, cyclamen purpurascens (HAB) D6 125 mg, datura stramonium (HAB) D12 (HAB 2a) 85 mg, delphinium staphisagria e semine (Staphysagria Ph.Eur.Hom.) spag. Peka D6 (HAB 47b) 125 mg, hypericum perforatum (HAB) D4 145 mg, kalium carbonicum (HAB) D4 (HAB 5a) 145 mg, viburnum opulus (HAB) D6 125 mg, xanthoxylon fraxineum e cortice D6 (HAB 4a) 125 mg, ethanolum 96 per centum, aqua purificata, ad solutionem pro 1 g, corresp. 1.02 ml, corresp. 45 guttae, corresp. ethanolum 20 % V/V.

Articles (1)

Upelva, Tropfen zum Einnehmen
Tropfen zum Einnehmen
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/07/2026
Patient information leaflet
Français
07/07/2026
Patient information leaflet
Italien
07/07/2026

Detailed composition

Substance Quantity Type Category
chamaelirium luteum (HAB)
125.0 MG Substance Wirkstoff (Principe actif)
cyclamen purpurascens (HAB)
125.0 MG Substance Wirkstoff (Principe actif)
datura stramonium (HAB)
85.0 MG Substance Wirkstoff (Principe actif)
delphinium staphisagria e semine (Staphysagria Ph.Eur.Hom.) spag. Peka
125.0 MG Substance Wirkstoff (Principe actif)
hypericum perforatum (HAB)
145.0 MG Substance Wirkstoff (Principe actif)
kalium carbonicum (HAB)
145.0 MG Substance Wirkstoff (Principe actif)
viburnum opulus (HAB)
125.0 MG Substance Wirkstoff (Principe actif)
xanthoxylon fraxineum e cortice
125.0 MG Substance Wirkstoff (Principe actif)
ethanolum 96 per centum
- Substance HBESI
aqua purificata
- Substance HNIDK

Authorization holder

ebi-pharm ag

3038 Kirchlindach

Authorization information

Swissmedic authorization number
55326
Drug name
Upelva, Tropfen zum Einnehmen
Galenic form
TROF
Authorization status
Z
Dispensation category
D
First authorization
08/02/2001
Authorization expiration date
31/12/9999
IT number
20.01.2.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild und dem Therapieprinzip der Spagyrik bei Menstruationsbeschwerden wie Krämpfen während der Periodenblutung, zu starker Periode.

Packaging details

Description (FR)
UPELVA gouttes buvables fl 50 ml
Description (DE)
UPELVA Tropfen zum Einnehmen Fl 50 ml
Market launch
08/02/2001
Narcotic (BTM)
No

Other packaging sizes

UPELVA gouttes fl 100 ml
100 ML
View
Buy us a coffee Explore the data